Ameriprise Financial, Inc., together with its subsidiaries, operates as a diversified financial services company in the United States and internationally. The company offers financial planning and advice services to individual and institutional clients. It operates through Advice & Wealth Management, Asset Management, and Retirement & Protection Solutions segments. The Advice & Wealth Management segment provides financial planning and advice; brokerage products and services for retail and institutional clients; discretionary and non-discretionary investment advisory accounts; mutual funds; insurance and annuities products; cash management and banking products; and face-amount certificates. The Asset Management segment offers investment management, advice, and products to retail, high net worth, and institutional clients through third-party financial institutions, advisor networks, direct retail, and its institutional sales force under the Columbia Threadneedle Investments brand name. Its products include U.S. mutual funds and their non-U.S. equivalents, exchange-traded funds, variable product funds underlying insurance, and annuity separate accounts; and institutional asset management products, such as traditional asset classes, separately managed accounts, individually managed accounts, collateralized loan obligations, hedge funds, collective funds, and property and infrastructure funds. The Retirement & Protection Solutions segment provides variable annuity products, as well as life and disability income insurance products to retail clients. The company was formerly known as American Express Financial Corporation and changed its name to Ameriprise Financial, Inc. in September 2005. Ameriprise Financial, Inc. was founded in 1894 and is based in Minneapolis, Minnesota.

Ameriprise Financial Inc.

J.P. Morgan analyst Anupam Rama upgraded CAMP4 Therapeutics Corporation to a Buy yesterday and set a price target of $9.00. The company’s shares cl...

Positive Report for CAMP4 Therapeutics Corporation (CAMP) from J.P. Morgan

AmpliTech Group ( ($AMPG) ) has shared an update. In March 2024, AmpliTech Group completed several digital currency transactions totaling about $3....

AmpliTech Faces Potential Derivative Suit Over Crypto Loss

The latest announcement is out from AMP ( ($AU:AMP) ). AMP Limited has announced the cancellation of 40,052,903 ordinary fully paid shares followin...

AMP Cancels 40 Million Shares After On‑Market Buy‑Back

In a report released today, Ted Jackson from Northland Securities maintained a Buy rating on Amprius Technologies Inc, with a price target of $24.0...

Amprius Technologies Inc (AMPX) Receives a Buy from Northland Securities

Insiders have been trading these 5 stocks: (($USAR)), (($CNC)), (($ONON)), (($ELV)) and (($AMPX)). Here is a breakdown of their recent trades and t...

USA Rare Earth, Centene, On, Elevance, Amprius Insider Shock

CAMP4 Therapeutics Corporation ( ($CAMP) ) just unveiled an announcement. On June 10, 2026, CAMP4 Therapeutics stockholders approved an amendment t...

CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan

An announcement from Amplitude ( ($AMPL) ) is now available. On June 9, 2026, Amplitude, Inc. held its 2026 annual meeting of stockholders, where i...

Amplitude Shareholders Back Directors, Auditor and Executive Pay

CAMP4 Therapeutics Corporation received a Buy rating and a $6.50 price target from Chardan Capital analyst Keay Nakae today. Nakae covers the Healt...

CAMP4 Therapeutics Corporation (CAMP) Receives a New Rating from Chardan Capital

Ameriprise Financial ( ($AMP) ) has issued an update. On June 9, 2026, Ameriprise Financial, Inc. raised $750 million in the debt markets by issuin...

Ameriprise Financial Issues $750 Million in Senior Notes

The latest update is out from AMP ( ($AU:AMP) ). AMP Limited has notified the market under an exemption in subsection 259C(2) of the Corporations A...

AMP trims controlled interest in its own shares, updates market on voting power

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on CVRx (CVRX), Ardent Health Partners, Inc. (ARDT) a...

Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Ardent Health Partners, Inc. (ARDT) and Amphastar Pharmaceuticals (AMPH)

Amplifon S.p.A. received a Buy rating and a €13.50 price target from Kepler Capital analyst Niccolo Guido Storer on May 25. The company’s shares cl...

Amplifon S.p.A. (0N61) was upgraded to a Buy Rating at Kepler Capital

The latest announcement is out from Amper SA ( ($ES:AMP) ). Amper, S.A. has acquired the assets and technological capabilities of Zeleros Global, a...

Amper Buys Zeleros Assets to Bolster Defense Tech Capabilities

The latest announcement is out from AMP ( ($AU:AMP) ). AMP Limited has disclosed an update to its on-market share buy-back program, confirming that...

Current Quarter	$10.5	Next Quarter	$10.81
Current Year	$42.69	Next Year	$46.15
QoQ Growth	+3.0%	YoY Growth	+8.1%
3Y EPS CAGR	N/A	Target Price	$540.25
Consensus	Buy	Upside	+15.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AMP	$466.11	-1.12%	801.92K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AMP	$466.11	-1.1%	801.92K
3
4
5
6

AMP

AMP

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get Ameriprise Financial Inc. Data in Excel

Get Ameriprise Financial Inc. Data in Excel